This site and its domain are for sale. Email the owner if you want to talk about it.

bioclocktest.com

Telomeres: The Ageing Marker That Underperformed

Telomere length has a tidy mechanism and a long track record, and it still keeps losing to clocks that simply count more things.

Close-up photograph of a frayed rope end beside a neat coil of rope on a wooden dock, suggesting wear at the ends.

A large study in the UK Biobank Pharma Proteomics Project (53,021 people, 2,923 proteins measured in their blood) built an ageing clock out of proteins and then compared it with older ways of estimating biological age. Its Proteomic Aging Clock, the study reported, “showed stronger age-adjusted associations with all-cause mortality and 18 incident diseases than PhenoAge, BioAge, or leukocyte telomere length.” The last item on that list is the interesting loser. It is the only one that sounds like a physical thing wearing out.

Telomeres are repetitive stretches of DNA at the ends of chromosomes. The textbook story is that they get shorter as cells keep dividing, which makes their average length in white blood cells an appealing stand-in for how used up a body is. As an age marker it works, sort of. It points in the expected direction and lines up with other ageing measures, but it keeps getting beaten by measures that combine many signals at once. Why it underperforms is not fully settled by the research here, but the explanations sort into a few groups.

What a telomere is and why it looked like the ideal clock

Most biological age measures are, at bottom, statistical. The Horvath clock, for instance, reads chemical tags at 353 spots on the genome and predicts chronological age with a mean absolute error of about 3.6 years, according to a summary by CD Genomics. Nobody claims those 353 spots are what ageing physically is. They are where the correlation lives.

Telomere length was the opposite pitch. It arrived with a mechanism already attached: cells divide, the ends get trimmed, and eventually the cell has trouble dividing. A marker with a story is a marker people like to measure. (I write about ageing tests for a living, which mostly means reading supplementary tables about weighted sums of CpG sites, so I understand the appeal of a ruler.) Telomere length is something like the win-loss record of ageing biology. It is easy to explain, it has been tracked forever, and it keeps getting printed next to the newer statistics that outperform it.

Why telomeres lose to other ageing measures

There are, roughly, three ways to read this. The first is that telomere length is a decent marker measured badly. The second is that it is measured well enough and simply carries less information than its competitors. The third, which is the least comfortable, is about what happens when a weak marker is pointed at an intervention and asked whether the intervention worked.

The first reading: the ruler wobbles

In the CALERIE 2 trial of long-term calorie restriction, researchers measured telomere length two ways. One was quantitative PCR, which estimates the amount of telomere DNA in a sample by copying it and tracking how fast the copies accumulate, reported as absolute telomere length. The other was a DNA methylation algorithm. Two methods for one quantity is a sign that people do not fully trust either (or that the grant had room for both).

How noisy is the PCR version, exactly? The facts behind this article do not give a number for that, so it is not settled here. What they do show is that noise is not unique to telomeres. Elysium Health, which sells a methylation-based test, says on its science page that “a single epigenetic age sample processed repeatedly can result in biological age estimates that vary up to nine years.” A separate reliability study found that PCGrimAge was the only clock to reach good biological reliability, with an intraclass correlation above 0.75 across repeated measurements.

So the fancier clocks wobble too. The point is that wobble matters more when the real differences between people are small. If two people truly differ by a little and your instrument jitters by a lot, the instrument mostly reports the jitter. That is less a failing of anyone holding the instrument than a property of instruments.

The second reading: one number against thousands

Telomere length is a single number. Actually, that undersells how odd it is. It is the averaged length of every chromosome end across a very large number of white blood cells, each cell at its own point in its own history, compressed into one figure. Calling that “one measurement” is like calling a city’s average commute one car trip.

And it is going up against clocks built from thousands of inputs. The UK Biobank proteomic clock used 2,923 proteins. A related proteomic clock reached a correlation of 0.92 with chronological age in a Chinese biobank cohort of 3,977 people and 0.94 in a Finnish cohort of 1,990. When something like that is lined up against one averaged length, the averaged length losing is not a scandal. It is arithmetic.

To be fair, telomere length does show up where you would expect it to. The proteomic study reported that “proteomic aging was associated with telomere length as a biological age-related measure,” which means the two are picking up some of the same underlying thing. In a study of virologically suppressed people with HIV, DNA methylation-predicted telomere length was significantly shorter than in people without HIV (p < 0.001). Group differences are real (which is a more modest compliment than it sounds).

The trouble is that group differences and individual prediction are different jobs. A marker can reliably separate two groups of hundreds of people and still tell any one of them very little. I assume that is why telomere length keeps appearing in study after study as one column among many, rather than as the headline. I can picture the planning meeting. (Invented dialogue, not from any source.) “We’ve got the DNA in the freezer already. Can we add telomeres?” “Sure, put it next to GrimAge.”

The third reading: the answer depends on when you look

This is the CALERIE 2 result in more detail, and it is the uncomfortable part. Over the first year, the intent-to-treat analysis “found no significant differences in telomere length attrition between the caloric restriction and control groups.” Over the full study, from baseline to 24 months, it again found no differences in telomere length change. But during the stretch from month 12 to month 24, which the trial called the weight maintenance period, both being in the restriction group and restricting more were associated with less absolute telomere shortening.

So: nothing in year one, something in year two, nothing across both years together. I don’t know how a reader is meant to hold all three at once. One way is that the effect needed a year to show up. Another is that a noisy marker measured at several timepoints will, presumably, produce some window that looks interesting. The facts here do not say which, and the trial does not resolve it.

It must be hard to run two years of calorie restriction on healthy adults and come away with flat telomeres, so you can see why the middle twelve months got a sentence of their own. That is not a criticism of the researchers. Reporting the sub-period is the honest thing to do. It just means the headline number for telomeres depends a lot on which calendar you pick up.

Then there is the second method. CALERIE also used DNAmTL, and so did a study of prenatal and childhood lead exposure, and so did a ten-year HIV cohort that assessed eight epigenetic clocks “plus a telomere length estimator.” In plain words, DNAmTL works like this: you skip the telomere, look at chemical tags elsewhere on the DNA that tend to go along with long or short telomeres, and make an educated guess. Its official name is DNA methylation-derived telomere length. I mean, it is a sensible tool, and it runs on the same chip as the clocks, so it costs a study nothing extra to report.

In those studies, telomere length is one more output of the methylation chip that runs the clocks that beat it, and nobody looks at a telomere at all.

Sources

  1. Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults
  2. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations
  3. Effect of long-term caloric restriction on telomere length in healthy adults: CALERIE™ 2 trial analysis
  4. The GrimAge clock corresponds to brain ageing and social determinants of health in people with HIV
  5. Prenatal and childhood lead exposure is prospectively associated with biological markers of aging in adolescence
  6. Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled HIV-1 Infection
  7. Four Aspects to Interpret Epigenetic Clock Results - CD Genomics
  8. The Science Behind Index | Elysium Health
  9. Biological versus Technical Reliability of Epigenetic Clocks and Implications for Disease Prognosis and Intervention Response

Bio Clock Test explains published research. It is not medical advice and it does not diagnose anything. We never recommend a test, a supplement or a treatment. Talk to a clinician about your health.

Read next